
Charles River Laboratories International Inc
NYSE:CRL

Intrinsic Value
The intrinsic value of one
CRL
stock under the Base Case scenario is
206.98
USD.
Compared to the current market price of 135.63 USD,
Charles River Laboratories International Inc
is
Undervalued by 34%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Charles River Laboratories International Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Charles River Laboratories International Inc
Balance Sheet Decomposition
Charles River Laboratories International Inc
Current Assets | 1.5B |
Cash & Short-Term Investments | 229.4m |
Receivables | 756.6m |
Other Current Assets | 520.3m |
Non-Current Assets | 6.1B |
Long-Term Investments | 214m |
PP&E | 2B |
Intangibles | 3.5B |
Other Non-Current Assets | 342.9m |
Free Cash Flow Analysis
Charles River Laboratories International Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Charles River Laboratories International Inc
Revenue
|
4B
USD
|
Cost of Revenue
|
-2.6B
USD
|
Gross Profit
|
1.4B
USD
|
Operating Expenses
|
-888.9m
USD
|
Operating Income
|
506.4m
USD
|
Other Expenses
|
-537.9m
USD
|
Net Income
|
-31.6m
USD
|
CRL Profitability Score
Profitability Due Diligence
Charles River Laboratories International Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Score
Charles River Laboratories International Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
CRL Solvency Score
Solvency Due Diligence
Charles River Laboratories International Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Charles River Laboratories International Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CRL Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for
CRL
is 150.62 USD
with a low forecast of 70.7 USD and a high forecast of 225.75 USD.
Dividends
Current shareholder yield for CRL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
CRL
stock under the Base Case scenario is
206.98
USD.
Compared to the current market price of 135.63 USD,
Charles River Laboratories International Inc
is
Undervalued by 34%.